Weston Brain Institute

• NCT07477431

  Collaborator, Phase 2, Recruiting, 40 people, 17 Mar 2026

• NCT03260920

  Collaborator, Phase 2, Status unknown, 112 people, 24 Aug 2017

• Apoptosis protein markers in comorbid type 2 diabetes mellitus and depression; relationships with cognitive performance, incident dementia, and white matter hyperintensities

  5 Aug 2026

• Reducing CETP activity prevents memory decline in an Alzheimer's disease mouse model

  RR172187, 3 Aug 2026

• Predicting continuous amyloid PET levels with CSF and plasma brain-derived p-tau217

  1 Aug 2026

• Differences in blood levels of neuroligin-derived peptides in a cohort for early detection of Alzheimer's disease

  RR192181, 10 Mar 2026

Sources: api.crossref.org

• Peripheral inflammation in a Canadian cohort of neurodegenerative conditions: Occurrence, determinants, and impact

  Grants or research support, 8 Dec 2025

• Executive Function Among Older Adults With Bipolar Disorder: A GAGE-BD Analysis

  Grants or research support, Board or leadership role, 7 Dec 2025

• Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

  Grants or research support, 1 Mar 2024

Sources: pubmed.ncbi.nlm.nih.gov